Rhodiola sp. can reduce TNF-α, transforming growth factor beta 1, and IL-6 levels in the BALF in a concentration-dependent manner and inhibit inflammatory injury caused by cerebral ischemia in rats, slowing the progression of brain edema [41]. The gene discussed is TGFB1; the disease is Cerebral ischemia.